Glioblastoma microenvironment-from biology to therapy.
Renee D ReadZoe M TappPrajwal RajappaDolores HambardzumyanPublished in: Genes & development (2024)
Glioblastoma (GBM) is the most aggressive primary brain cancer. These tumors exhibit high intertumoral and intratumoral heterogeneity in neoplastic and nonneoplastic compartments, low lymphocyte infiltration, and high abundance of myeloid subsets that together create a highly protumorigenic immunosuppressive microenvironment. Moreover, heterogeneous GBM cells infiltrate adjacent brain tissue, remodeling the neural microenvironment to foster tumor electrochemical coupling with neurons and metabolic coupling with nonneoplastic astrocytes, thereby driving growth. Here, we review heterogeneity in the GBM microenvironment and its role in low-to-high-grade glioma transition, concluding with a discussion of the challenges of therapeutically targeting the tumor microenvironment and outlining future research opportunities.
Keyphrases
- stem cells
- high grade
- white matter
- single cell
- resting state
- induced apoptosis
- peripheral blood
- room temperature
- gold nanoparticles
- papillary thyroid
- bone marrow
- acute myeloid leukemia
- cell cycle arrest
- cerebral ischemia
- multiple sclerosis
- cell therapy
- signaling pathway
- mesenchymal stem cells
- spinal cord injury
- brain injury
- blood brain barrier
- wastewater treatment
- electron transfer
- molecularly imprinted
- pi k akt